Skip to content

Drug interactions

Carvedilol + Repotrectinib

Severity: Moderate

Carvedilol and Repotrectinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Carvedilol inhibits P-glycoprotein and could modestly raise exposure to repotrectinib, which is a P-gp substrate. Higher repotrectinib levels may increase neurologic and other dose-related adverse effects.

What this interaction means in plain words

Carvedilol and Repotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Carvedilol belongs to Cardiovascular; Repotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Carvedilol inhibits intestinal P-glycoprotein efflux, potentially increasing repotrectinib absorption.

What to do

Monitor for repotrectinib adverse effects such as dizziness, ataxia and paresthesia when carvedilol is started or stopped. Reduce the repotrectinib dose if toxicity appears.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Carvedilol and Repotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Carvedilol with Repotrectinib?

MediHelp rates the interaction as moderate. Carvedilol and Repotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Carvedilol inhibits P-glycoprotein and could modestly raise exposure to repotrectinib, which is a P-gp substrate. Higher repotrectinib levels may increase neurologic and other dose-related adverse effects.

How serious is the interaction between Carvedilol and Repotrectinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for repotrectinib adverse effects such as dizziness, ataxia and paresthesia when carvedilol is started or stopped. Reduce the repotrectinib dose if toxicity appears.

What other medicines interact with Carvedilol?

MediHelp also lists interactions of Carvedilol with, for example, Amifostine, Amiodarone, Arformoterol. The full list is on the Carvedilol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in